Alembic Pharma share slips 5% after Q4 earnings- Business News

Alembic Pharma share slips 5% after Q4 earnings
For FY21, the company posted a net profit of Rs 1178 crore compared to Rs 829 crore in the previous year, up 42 per cent
BusinessToday.In | May 5, 2021 | Updated 15:49 IST
Representative Image
Share of Alembic Pharma declined over 5 per cent in early trade today after the company reported earnings for the quarter ended March 2021. The stock hit an intraday low of Rs 948 and an intraday high of Rs 1,003.
The company reported a net profit of Rs 251 crore for Q4 FY21 compared to Rs 225 crore for the corresponding quarter of the previous year, an increase of 11.5 per cent.

Related Keywords

Pranav Amin ,International Business ,Alembic Pharmaceuticals ,Us Food Drug Administration ,Alembic Pharma ,Managing Director ,Pharmaceuticals Limited ,Drug Administration ,Abbreviated New Drug Application ,Timolol Maleate Ophthalmic Solution ,Lembic Pharma Stock ,Alembic Pharma Shares ,Lembic Pharma Share ,S Fda ,March Quarter Earnings ,பிரணவ் அமின் ,சர்வதேச வணிக ,அலெம்பிக் மருந்துகள் ,அலெம்பிக் பார்மா ,நிர்வகித்தல் இயக்குனர் ,மருந்துகள் வரையறுக்கப்பட்டவை ,